Skip to main content
HR 5582 115th Congress House Health Congressional oversight Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government studies and investigations Health care costs and insurance Health care coverage and access Health promotion and preventive care Medicare Prescription drugs

Abuse Deterrent Access Act of 2018

Introduced: April 23, 2018 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5061)
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5061)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5582.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5061-5063)
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Jun 8, 2018
Placed on the Union Calendar, Calendar No. 556.
Jun 8, 2018
Committee on Ways and Means discharged.
Jun 8, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-721, Part I.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
May 1, 2018
Referred to the Subcommittee on Health.
Apr 23, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 23, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Abuse Deterrent Access Act of 2018

(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.

What's happening now June 13, 2018

Received in the Senate and Read twice and referred to the Committee on Finance.

 Related & companion bills 1
  • HR 6 Related bill SUPPORT for Patients and Communities Act
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 3
All 3 Republican 1
R
Blackburn, Marsha
Tennessee · May 11, 2018
McHenry, Patrick
· May 11, 2018
WALDEN, GREG
· May 11, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5582: Abuse Deterrent Access Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5582/
MLA
"H.R. 5582: Abuse Deterrent Access Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5582/.
Bluebook (legal)
H.R. 5582, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5582/.
Markdown link
[H.R. 5582: Abuse Deterrent Access Act of 2018](https://openamerica.io/bill/115-HR-5582/)
Report a problem